Aposense Ltd.
๐ฎ๐ฑIsrael
- Country
- ๐ฎ๐ฑIsrael
- Ownership
- Public, Subsidiary
- Established
- 1996-01-01
- Employees
- 12
- Market Cap
- -
- Website
- http://www.aposense.com
An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and Radiation
Phase 2
- Conditions
- Carcinoma, Non-Small-Cell LungHead and Neck Neoplasms
- Interventions
- Other: [18F]-ML-10 in conjunction with PET imaging
- First Posted Date
- 2010-12-15
- Last Posted Date
- 2010-12-17
- Lead Sponsor
- Aposense Ltd.
- Target Recruit Count
- 60
- Registration Number
- NCT01260480
- Locations
- ๐บ๐ธ
BWH, Boston, Massachusetts, United States
๐บ๐ธHoly Name Medical Center, Teaneck, New Jersey, United States
๐บ๐ธMount Sinai, New York, New York, United States
Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy.
Phase 2
- Conditions
- Solid TumorsBrain Metastases
- First Posted Date
- 2008-12-09
- Last Posted Date
- 2010-05-12
- Lead Sponsor
- Aposense Ltd.
- Target Recruit Count
- 30
- Registration Number
- NCT00805636
- Locations
- ๐บ๐ธ
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
๐บ๐ธUPMC Shadyside Radiation Oncology, Pittsburgh, Pennsylvania, United States
๐บ๐ธDepartment of Radiation oncology, Memorial Sloan Kettering Cancer Center, New York city, New York, United States
18F ML-10 for Early Detection of Response of Brain Metastases to WBRT
Phase 2
Completed
- Conditions
- Solid TumorsBrain Metastases
- Interventions
- Other: 18F ML-10
- First Posted Date
- 2008-11-14
- Last Posted Date
- 2013-02-13
- Lead Sponsor
- Aposense Ltd.
- Target Recruit Count
- 10
- Registration Number
- NCT00791063
18F ML-10 for Early Detection of Response of Brain Metastases to SRS
Phase 2
Terminated
- Conditions
- Metastasis to Brain of Unknown Primary
- Interventions
- Drug: ([18F]-ML-10)
- First Posted Date
- 2008-06-13
- Last Posted Date
- 2013-02-15
- Lead Sponsor
- Aposense Ltd.
- Target Recruit Count
- 1
- Registration Number
- NCT00696943
ยฉ Copyright 2025. All Rights Reserved by MedPath